Prilenia signs deal for former Teva ALS drug worth up to 500m
Israeli-Dutch scientific stage biotech firm Prilenia Therapeutics has introduced a collaboration and licensing settlement for its lead drug Pridopidine, ...
Thursday, March 19, 2026
Tag: ALS
NeuroSense schedules FDA meeting for ALS drug trial By Investing.com
CAMBRIDGE, Mass. - NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a biotech agency specializing in neurodegenerative illness therapies, has secured a Kind ...
RECOMMENDED
The Music Has Stopped in Private Markets – CFA Institute Enterprising Investor
Two Many years of Extra Funding is Trapped in Personal Markets When the music stops, when it comes to liquidity,...
Copyright © 2024 PWC.